Sleep and circadian homeostasis are important for overall well-being. Increasing evidence points to a specific pivotal role that sleep and circadian system play in brain health (Abbott and Videnovic, 2016; Musiek and Holtzman, 2016) . Neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's diseases are common neurological disorders, and are become more prevalent as the population ages. These conditions share disturbed sleep as a common and yet frequently overlooked manifestation. Further, disrupted sleep and circadian rhythms frequently predate the onset of cardinal features of these disorders. Sleep and circadian system are therefore positioned as important potential therapeutic targets for improving function and quality of life of patients affected by neurodegenerative disorders. This special issue is centered on the interface of sleep, circadian biology and neurodegeneration, and incorporates a combination of original research papers and comprehensive reviews on this rapidly evolving and promising avenue of investigation.
the function of the circadian system in PD, and encompasses both basic and clinical research investigations on the topic.
Colwell and colleagues report beneficial effects of supplemental light exposure on the BACHD and Q175 mice models of HD. Animals were exposed daily for 3 months to 6 h to blue-enriched light at the beginning of their daily light cycles. The intervention resulted in improvements in locomotor activity rhythms and motor performance without change in sleep in both animal models of the disease. Further, blue-enriched light alters the expression of HD relevant markers in the cortex and striatum. In another study published in this special issue, Morton and colleagues report effects of prolonged day light exposure on daytime activity and circadian behavioral rhythms in R6/2 mice model of HD that demonstrated profound alterations in circadian rhythms by the age of 16 weeks. A long day photoperiod (16 h light/8 h dark) was associated with improved survival and circadian strength, while short day photoperiod had a negative impact on survival in this animal mode of HD. These two investigations further strengthen the notion that circadian based interventions may be a novel approach in the symptomatic treatment and modification of neurodegenerative process itself. The studies align with several other investigations that reported beneficial effects of circadian interventions in movement disordered in both patients and animal models of these disorders (Pallier et al., 2007; Paus et al., 2007; Willis and Turner, 2007) .
While not typically considered neurodegenerative disorders, both traumatic brain injury (TBI) and stroke lead to degeneration of neurons, and can be associated with sleep and circadian deficits (Baumann et al., 2007; Meng et al., 2008) . TBI shares common molecular mechanisms with AD, including tau aggregation, and is characterized by ongoing synapse loss, inflammation, and neurodegeneration well after the initial injury (McKee and Daneshvar, 2015) . TBI patients frequently experience disabling disturbances of sleep and circadian rhythm, and these deficits can be modeled in animals (Baumann et al., 2007; Boone et al., 2012; Grima et al., 2016; Lim et al., 2013; Shekleton et al., 2010) . In this issue, Yue et al. describe circadian fluctuations in the Glasgow Coma Scale in TBI patients, suggesting that the time of day at which an injury occur may effect severity and ICU admission rate. Two other original research papers in this issue provide novel insights into the effects of TBI on sleep and wakefulness. Thomasy and colleagues present evidence that TBI causes an increase in non-REM sleep and diminished nighttime wakefulness in mice, an effect associated with specific loss of orexin/hypocretin and cholinergic neurons. Modarres et al. demonstrate that TBI in both humans and mice is associated with increased amounts of slow wave activity and desynchronized slow waves during wakefulness, offering a potential biomarker of TBIrelated impairment in humans. While the incidence of ischemic stroke and the sensitivity of tissue to ischemic damage are both influenced by the time of day (Bassetti and Aldrich, 1999; Elliott, 1998; Karmarkar and Tischkau, 2013) , sleep may also play a role in healing of the brain after infarction. Duss et al. examine the evidence linking sleep to synaptic plasticity and sleep deprivation to impaired brain recovery following stroke. They suggest that augmenting sleep in the post-stroke period might be a strategy to promote rewiring of the brain and functional recovery after stroke.
Sleep and circadian rhythms influence a wide variety of physiologic processes in the brain and periphery, many of which are critical to brain health. However, the cellular and molecular mechanisms linking sleep, circadian function, and neurodegeneration are just beginning to be uncovered (Musiek and Holtzman, 2016; Videnovic et al., 2014a) . The contributions in this special issue of Neurobiology of Sleep and Circadian Rhythms reveal the cutting edge in this field, and illustrate what we know and how much we have to yet to understand. These studies keenly demonstrate the importance of research on sleep, rhythms, and neurodegenerative disorders, and provide several unique examples of how sleep and circadian systems might be targeted to ameliorate these terrible diseases.
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